Clinuvel
is an Australia-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of genetic and metabolic disorders... Read moreClinuvel
is an Australia-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of genetic and metabolic disorders... Read more
Annual Revenue
$58.8M
Employees
27
News
Apr 01, 2025
Stockhead
Clinuvel: Biocurious: While other biotechs scratch around for cash, Clinuvel is accused of having too much
Mar 26, 2025
Finance News Network
Clinuvel: Clinuvel reports positive early results for stroke treatment study
Mar 04, 2025
Benzinga
Clinuvel: Clinuvel Introduces Groundbreaking Vitiligo Program at the World's Biggest Dermatology Meeting, AAD 2025
Feb 28, 2025
Seeking Alpha
Clinuvel: Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2025 Earnings Call Transcript
Feb 20, 2025
Clinuvel Youtube Channel
Clinuvel posted a video "A focused strategy that must continue: Non-Executive Director, Guy van Dievoet" on YOUTUBE
Feb 16, 2025
Clinuvel Youtube Channel
Clinuvel posted a video "CLINUVEL is on the cusp of realising exciting opportunities: Non-Executive Director Matthew Pringle" on YOUTUBE
Feb 10, 2025
centralcharts
Press Release: Clinuvel : PARMANTIER & CIE. Provides an Update on CLINUVEL Pharmaceuticals
Nov 20, 2024
Finance News Network
Clinuvel: Injecting hope: Clinuvel eyes higher SCENESSE usage in Europe
Nov 17, 2024
Finance News Network
Clinuvel: Clinuvel narrows focus to prioritise key programs
Sep 30, 2024
StreetInsider
Press Release: Clinuvel : CLINUVEL files Canadian New Drug Submission for SCENESSE in EPP
Clinuvel Competitors
1
2
3
4
5
6
7
8
9
10